Streetbeat News

Stock Prices

SGMO

Sangamo Therapeutics (NASDAQ:SGMO) has received various analyst ratings in the last quarter, with 2 bullish, 4 somewhat bullish, and 2 indifferent. Over the past 3 months, 8 analysts have offered 12-month price targets for the company, with an average price target of $5.5, a decrease of 38.89% from the previous average price target of $9.00.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 3:00 pm

PARA

Over the past 3 months, 9 analysts have published their opinion on Paramount Global (NASDAQ:PARA) stock. The analysts have an average price target of $13.56 versus the current price of Paramount Global at $13.335. This current average represents a 28.63% decrease from the previous average price target of $19.00.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 3:00 pm

BNBUSD

BNB's price has risen 5.13% to $253.36 in the past 24 hours, continuing its positive trend over the past week with a 9.0% gain. The coin's trading volume has climbed 62.0% over the past week and the circulating supply has increased 0.02% to 153.86 million, which makes up an estimated 76.93% of its max supply of 200.00 million. The current market cap ranking for BNB is #5 at $38.78 billion.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 3:00 pm

AWK

American Water Works (NYSE:AWK) has outperformed the market over the past 10 years, producing an average annual return of 11.84%. If an investor had bought $1000 of AWK stock 10 years ago, it would be worth $3,036.00 today.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 3:00 pm

PAA

In the last quarter, Plains All American (NASDAQ:PAA) received mixed analyst ratings. The average price target is $16.25, slightly above the current price of $15.965. The average price target has increased by 4.84% over the past month.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 3:00 pm

META

Meta Platforms (NASDAQ:META) has outperformed the market over the past 10 years by 11.68% on an annualized basis, producing an average annual return of 21.11%. If an investor had bought $1000 of META stock 10 years ago, it would be worth $6,846.54 today.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 3:00 pm

XRPUSD

XRP's price has increased by 12.14% over the past 24 hours to $0.72, and by over 23.0% over the past week. The trading volume for the coin has increased by 84.0% over the past week, while the overall circulating supply of the coin has increased by 0.04% to over 53.62 billion. The current market cap ranking for XRP is #4 at $39.03 billion.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 3:00 pm

FIVN

In the last quarter, Five9 (NASDAQ:FIVN) received 5 bullish, 2 somewhat bullish, and 1 indifferent analyst rating. Over the past 3 months, 8 analysts have offered 12-month price targets for Five9, with an average price target of $87.25, a decrease of 5.78% from the previous average price target of $92.60.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 3:00 pm

DBGI

Shares of Digital Brands Group (DBGI) were halted on a circuit breaker after a significant increase of 45.4%. Trading resumed but was halted again due to downside movement.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 2:59 pm

APLS

Citron Research has released a report on Apellis Pharmaceuticals (APLS), stating that the company's successful days are over due to concerns over its drug, Syfovre. The drug, used for treating Geographic Atrophy, has been linked to retinal vasculitis, a side effect that has caused the company's stock to drop. Despite these reports, Apellis continues to stand by the safety of Syfovre.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 2:58 pm